1. Introduction {#sec1}
===============

Fluoroquinolones (FQs) are the important antibiotics used for the treatment of Gram-negative bacterial infections in both human and veterinary medicine. They are derivatives of 4-quinolone, which have unsubstituted or substituted piperazine ring attached at the 7-position to the central ring system of quinoline as well as fluorine atom at the 6-position. The FQs are useful to treat a variety of infections, including soft-tissue infections, respiratory infections, urinary tract infections, bone-joint infections, typhoid fever, prostatitis, sexually transmitted diseases, acute bronchitis, community-acquired pneumonia, and sinusitis \[[@B1]--[@B3]\].

Ciprofloxacin (CFX), which is one of the second-generated groups of synthetic FQs, can exhibit greater intrinsic antibacterial activity and make a broader antibacterial spectrum. Ofloxacin (OFX) is a chiral compound that is widely used to treat above infections. Levofloxacin (LFX) is the pure (--)-(S)-enantiomer of the racemic drug substance ofloxacin. Figures [1(a)](#fig1){ref-type="fig"}--[1(c)](#fig1){ref-type="fig"} show the chemical structures of CFX, LFX, and OFX, respectively.

Several techniques like voltammetry \[[@B4]\], flow injection electrogenerated chemiluminescence \[[@B5]\], spectrofluorometry \[[@B6], [@B7]\], spectrophotometry \[[@B8], [@B9]\], high-performance liquid chromatography \[[@B10], [@B11]\], and liquid chromatography tandem mass spectrometry \[[@B12], [@B13]\] have been used for the determination of fluoroquinolones in pharmaceutical and biological products. Among them, spectrophotometric method has several advantages such as simplicity, fast, and low cost. Spectrophotometry was successfully used for pharmaceutical analysis, involving quality control of commercialized product and pharmacodynamic studies. Spectrophotometric methods for the determination of fluoroquinolones could be classified according to the different reactions: (i) charge-transfer complexation based on the reaction of FQs as electron donors with p-acceptors such as 2,3-dichloro-5,6-dicyano-q-benzoquinone, 7,7,8,8-tetracyanoquinodimethane, q-chloranil, q-nitrophenol, and tetracyanoethylene \[[@B7], [@B14]--[@B16]\]; (ii) oxidative coupling reaction using oxidative coupling with 3-methyl-2-benzothiazolinonehydrazone hydrochloride and cerium (IV) ammonium sulfate, Fe(III)-MBTH, tris(*o*-phenanthroline) iron(II), and tris (bipyridyl) iron(II) \[[@B17], [@B18]\]; (iii) ion-pair complex formation with acid-dye reagents such as Sudan III, methyl orange, supracene violet 3B, tropaeolin 000, bromophenol blue, bromothymol blue, bromocresol green, and bromocresol purple \[[@B8], [@B14], [@B19], [@B20]\]. These methods were related with some major drawbacks such as having narrow linearity range, requiring heating and close pH control, long time for the reaction to complete, and low stability of the colored product formed.

Bromothymol blue (BTB) ([Figure 1(d)](#fig1){ref-type="fig"}) is an anionic dye and that can be protonated or deprotonated to form yellow or blue, respectively. The BTB was used to make ion-pair complex, which was applied to determine many pharmaceutical compounds by extractive spectrophotometric methods \[[@B21]--[@B30]\]. However, the ion-pair complex between BTB and FQs has not been studied. The method based on ion-pair complexes between analytes and BTB into a suitable organic solvent is also simple, fast, and cheap.

In the previous study, we used sulphonphthalein acid including bromophenol blue, bromocresol green, and bromothymol blue to determine ciprofloxacin pharmaceutical formulations and achieved good results \[[@B31]\].

In this paper, for the first time, we investigated extractive spectrophotometric method based on the formation of ion-pair complexes between ciprofloxacin, levofloxacin, and ofloxacin with BTB subsequent extraction into chloroform. Some effective conditions on the formation of complexes such as pH, shaking time, organic solvent, and the concentration of dye were systematically studied. The present method was also applied to determine FQs in some pharmaceutical formulations including tablets and infusions.

2. Experimental {#sec2}
===============

2.1. Apparatus {#sec2.1}
--------------

A double beam UV-visible spectrophotometer (SP-60, Biochrom Ltd., UK) with 1.0 cm of path length quartz cells was used to measure all sample absorbances. Inolab pH-meter instrument (Germany) was used to monitor the pH of solutions. Three standard buffers were used to calibrate the electrode before measuring pH of solutions. All measurements were conducted at 25 ± 2°C controlled by air conditional laboratory.

2.2. Materials and Reagents {#sec2.2}
---------------------------

All chemicals used were of analytical grade and double-distilled water was used to prepare all solutions in the present study.

FQs were purchased from Sigma (Germany, with purity \>99.0%), whereas bromothymol blue (BTB) was supplied by Maya-R, China, with purity \>99%. The organic solvents including chloroform, dichloromethane, carbon tetrachloride, dichloroethane, benzene, toluene, and other chemicals are analytical reagents (Merck, Germany).

The following dosage forms containing FQs were purchased from local pharmacy market and employed in the study: Hasancip and Kacipro tablets equivalent to 500 mg ciprofloxacin (Hasan-Dermapharm and Dong Nam manufacturing-Trading pharmaceutical Co., Ltd, Vietnam). Ciprofloxacin infusion equivalent to 200 mg ciprofloxacin/100 ml solution for infusion (Hebei Tiancheng Pharmaceutical Co., Ltd and Shandong Hualu Pharmaceutical Co., Ltd, China). Stada and DHG tablets equivalent to 500 mg levofloxacin (Stada-VN J.V.Company and DHG pharmaceutical joint--stock company, Vietnam). Ofloxacin (200 mg/tablet) was provided by the Mekophar Chemical Pharmaceutical Company (Vietnam).

2.3. Solution Preparation {#sec2.3}
-------------------------

A stock solution of FQs (1 mg/mL) in double-distilled water. The working standard solution of FQs containing 100 *µ*g/mL was prepared by appropriate dilution. The stock solution of BTB (0.025%) was prepared in double-distilled water. All stock solutions were kept in dark bottle, stored in 4°C and could be used within one week.

2.4. Construction of Calibration Curves {#sec2.4}
---------------------------------------

A series of 125 mL separating funnel, the volumes of working solutions of the drugs in different concentration ranges (CFX (1--35 *µ*g/mL), LFX (0.5--25 *µ*g/mL), and OFX (0.5--25 *µ*g/mL) were transferred. Then, 4.0 mL of 0.025% BTB solution was added before thoroughly mixing. After that, a 10 mL of chloroform was added to each of the separating funnel. The contents were shaken for 2 min and allowed to separate the two layers. The yellow-colored chloroform layer containing the ion-pair complexes was measured at 420 nm for CFX, 415 nm for LFX, and 418 nm for OFX against the reagent blanks. At each concentration, the experiment was repeated 6 times. The colored chromogen complexes are stable for 24 h.

2.5. Sample Preparation {#sec2.5}
-----------------------

Weigh and mix the contents of twenty tablets of each drug (CFX, LFX, and OFX), an accurately weighed amount of powder equivalent to 0.1 g of drugs transferred into a 100-mL beaker. A magnetic stirrer was used to completely disintegrate the powder in doubly distilled water. Then, filter through a Whatman paper (No 40) and fill up to 100 mL with doubly distilled water in a volumetric flask. The working solution of the drugs containing 100 *µ*g/mL was prepared by dilution and determined under optimum conditions.

2.6. Validation with High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) {#sec2.6}
---------------------------------------------------------------------------------------

Some real samples of three FQs were determined by HPLC-MS using HPLC 20 AXL (Shimadzu, Japan) coupled with electrospray ionisation tandem mass spectrometric detection, ABI 5500 QQQ (Applied BioSystem). The chromatographic conditions are including column C18 MRC-ODS (150 mm × 2.1 mm × 3.5 *µ*m), mobile phase containing acetonitrile (ACN) with formic acid (0.1%) in water under a flow rate of 0.5 ml/min, and gradient elution. The inject volume is 10 *µ*L.

3. Results and Discussion {#sec3}
=========================

3.1. Optimum Reaction Conditions {#sec3.1}
--------------------------------

### 3.1.1. Effect of Extracting Solvent {#sec3.1.1}

Six organic solvents including chloroform, carbon tetrachloride, dichloromethane, dichloroethane, benzene, and toluene were used to study the effect of solvent to ion-pair formation between FQs and BTB. [Figure 2](#fig2){ref-type="fig"} shows that chloroform is the most suitable solvent for the extraction of three FQs with low blank absorbance, highest absorbances, and lowest standard deviations. It implies that chloroform is the best extracting solvent to achieve a good recovery of the complexes with the shortest time to reach the equilibrium processes.

### 3.1.2. Effect of pH {#sec3.1.2}

The pH of solution plays an important role in the complex formations. The effect of pH on the formation of ion pairs was examined by varying the pH from 2.0 to 6.0 by adjusting 1 M HCl and 1 M NaOH. The maximum absorbances were observed at pH 3.3, 3.4, and 3.5 for the complexes of BTB and OFX, CFX, and LFX, respectively ([Figure 3](#fig3){ref-type="fig"}). These pH values correspond to the initial pH of the examined drug and the dye. Therefore, it is not necessary to adjust the pH before extraction.

### 3.1.3. Effect of Dye Concentration {#sec3.1.3}

The effect of dye concentrations was studied by adding different volumes of 0.025% BTB from 1.0 to 6.0 mL with a fixed concentration of FQs (10 *μ*g/mL) ([Figure 4](#fig4){ref-type="fig"}). [Figure 4](#fig4){ref-type="fig"} shows that the maximum absorbance of the complex was achieved with 4.0 mL of 0.025% of BTB in each case and excess dye did not affect the absorbance of the complex. Therefore, 4.0 mL of 0.025% of BTB is optimum dye volume and it is kept as constant for further studies.

### 3.1.4. Effect of Shaking Time {#sec3.1.4}

The effect of shaking time on the formation and stability of the ion-pair complex was investigated by measuring the absorbance of the extracted ion associates with increasing time from 0 to 4.0 min. [Figure 5](#fig5){ref-type="fig"} shows that the ion-pair complexes were formed instantaneously with 2.0 min shaking time. Thus, 2.0 min is the optimum shaking time and it is fixed for further studies.

### 3.1.5. Stoichiometry of Ion-Pair Complexes {#sec3.1.5}

Job\'s method of continuous variation of equimolar solutions was employed to evaluate stoichiometry of the complex. A 3.0 × 10^−4^ M standard solution of three FQs and 3.0 × 10^−4^ M solution of BTB were used. A series of the solutions were prepared in which the total volume of drug and reagent was kept in 10 mL, whereas the absorbances were measured at 420, 415, and 418 nm, for CFX, LFX, and OFX, respectively. The absorbances were plotted against the mole fraction of the drugs. The stoichiometry for each drug-dye ion-pair complex was found to be 1 : 1 ([Figure 6](#fig6){ref-type="fig"}).

### 3.1.6. Mechanism of Reaction and Absorption Spectra {#sec3.1.6}

Fluoroquinolones can contain a secondary amino group (CFX) and a tertiary amino group (LFX and OFX) that can be easily protonated under acidic conditions. On the one hand, the sulphonic acid group in BTB, that is, the only group undergoing dissociation in the pH range 1--5. The colour of BTB is on the basis of lactoid ring and subsequent formation of quinoid group. It is suggested that the two tautomers are plausible in equilibrium due to strong acidic nature of the sulphonic acid group. Thus, the quinoid body must predominate. Finally, the protonated fluoroquinolones form ion pairs with BTB dye that could be quantitatively extracted into chloroform. The possible reaction mechanisms are proposed and given in a scheme in [Figure 7](#fig7){ref-type="fig"}.

The absorption spectra of the ion-pair complexes, which were formed between FQs and BTB, were measured in the wavelength range 350--500 nm against the blank solution and shown in [Figure 8](#fig8){ref-type="fig"}.

[Figure 8](#fig8){ref-type="fig"} shows that absorption maxima for CFX-BTB, LFX-BTB, and OFX-BTB in chloroform were observed at 420, 415, and 418 nm, respectively. The reagent blanks under similar conditions have insignificant absorbances. At wavelengths 420, 415, and 418 nm, absorption spectrum of BTB does not affect the absorption spectrum of ion-associate complexes of FQs. Therefore, the selectivity of the proposed method for the determination of FQs is guaranteed.

### 3.1.7. Association Constants of Ion-Pair Complexes {#sec3.1.7}

The equation of association constant of ion-pair complex is$$\begin{matrix}
{\frac{A/A_{\text{m}}}{\left\lbrack {1 - \left( {A/A_{\text{m}}} \right)} \right\rbrack^{n + 2}C_{\text{M}{(n)}n}},} \\
\end{matrix}$$where *A* and *A* ~m~ are the observed absorbance and the maximum absorbance value when all the drug present is associated, respectively. *C* ~M~ is the molar concentration of the drugs at the maximum absorbance and n is the stoichiometry in which BTB ion associates with drugs. The conditional stability constants (K~f~) of the ion-pair complexes according to Britton \[[@B32]\] for the cases of FQs were calculated from the continuous variation data using the following equation:$$\begin{matrix}
{K_{f} = \frac{A/A_{\text{m}}}{\left\lbrack {1 - A/A_{\text{m}}} \right\rbrack^{n + 2}C_{\text{M}}\left( n \right)^{n}}.} \\
\end{matrix}$$The conditional stability constants (*K* ~*f*~) of the ion-pair complexes for FQs are indicated in [Table 1](#tab1){ref-type="table"}.

[Table 1](#tab1){ref-type="table"} shows that the log K~f~ values of ion-pair associates for OFX-BTB, LFX-BTB, and CFX-BTB were 6.08 ± 0.46, 6.04 ± 0.58, and 5.91 ± 0.32, respectively (numbers of replicated experiments, *n*=6). The obtained results confirmed that the ion-pair formation complexes are of high stability.

3.2. Validation of the Present Method {#sec3.2}
-------------------------------------

The proposed methods are validated according to ICH recommendations Q2(R1) \[[@B33]\]. The parameters that have been investigated are indicated below.

### 3.2.1. Linearity, Sensitivity, and Limits of Detection and Quantification {#sec3.2.1}

A linear relationship between the measured absorbance and the concentration range studied for each drug as shown in [Figure 9](#fig9){ref-type="fig"} and the correlation coefficient (R) of at least 0.997 were achieved. The limit of detection (LOD) and quantification (LOQ) of the method are determined by 3.3(*SD*/*b*) and 10(*SD*/*b*), respectively, where SD is the standard deviation of blank absorbance values and b is the slope of the calibration curve equation.

The LOD and LOQ values, slope, and intercept of linear graphs for all the drugs and analytical parameters are indicated in [Table 2](#tab2){ref-type="table"}. The molar absorptivities and Sandell\'s sensitivity of each methods were calculated and these values showed that the molar absorptivity of ion-pair complexes was in the order CFX-BTB \> LFX-BTB \> OFX-BTB.

### 3.2.2. Accuracy and Precision {#sec3.2.2}

The accuracy and precision of the methods were determined by preparing solutions of three different concentrations of drug and analyzing them in six replicates. The precision of the proposed methods was evaluated as percentage relative standard deviation (RSD%) and accuracy as percentage relative error (RE%). The percentage relative error was calculated using the following equation:$$\begin{matrix}
{{RE}\left( \% \right) = \left\lbrack \frac{\left( {{founded}–{added}} \right)}{added} \right\rbrack \times 100.} \\
\end{matrix}$$

The accuracy and precision were summarized in [Table 3](#tab3){ref-type="table"}. The low values of the RSD and RE confirm the high precision and the good accuracy of the present method.

### 3.2.3. Robustness and Ruggedness {#sec3.2.3}

For the evaluation of the method robustness, some parameters were interchanged: pH, dye concentration, wavelength range, and shaking time. The capacity remains unaffected by small deliberate variations. Method ruggedness was expressed as RSD% of the same procedure applied by two analysts and using different instruments on different days. The results showed no statistical differences between different analysts and instruments, suggesting that the developed methods were robust and rugged ([Table 4](#tab4){ref-type="table"}).

### 3.2.4. Selectivity and Effect of Interferences {#sec3.2.4}

The effect of commonly utilized excipients in drug formulation was studied. The investigated FQs were studied with various excipients such as magnesium stearate, glucose, lactose, starch, and sodium chloride which were prepared in the proportion corresponding to their amounts in the real drugs with a final dosage of 10 *µ*g/mL FQ. The effect of excipients on the determination of FQs was evaluated by recovery when determining FQs analyzed with the proposed method in the presence of excipient ([Table 5](#tab5){ref-type="table"}).

The results in [Table 5](#tab5){ref-type="table"} show that the recoveries are in the range of 98.53--102.04, demonstrating that there is no interference of excipients when FQs in drugs are quantified by extractive spectrophotometric using ion-pair formation with BTB. In other words, the present method has a high selectivity for determining FQs in its dosage forms.

3.3. Comparison with Other Spectrophotometric Methods {#sec3.3}
-----------------------------------------------------

The proposed method compares with other reported methods. It has been observed that the extractive spectrophotometric method with BTB in the present study is of high sensitivity than other ones ([Table 6](#tab6){ref-type="table"}). It also does not need heating, the product is stable for a longer time, and the interferences are minimum.

3.4. Analysis of Pharmaceutical Formulations {#sec3.4}
--------------------------------------------

The proposed method was applied successfully for the determination of studied drugs in the pharmaceutical formulations (tablets and infusion) and the results are presented in [Table 7](#tab7){ref-type="table"}. Six replicated determinations were measured. [Table 7](#tab7){ref-type="table"} shows that satisfactory recovery data were obtained and the recovery efficiency varies from 97.41% to 101.20%, indicating high accuracy of the present method in determining real pharmaceutical samples.

3.5. Comparison with HPLC-MS Method {#sec3.5}
-----------------------------------

In order to validate the experimental data in determining some real drug samples, HPLC-MS was used with the conditions described on [Section 2.6](#sec2.6){ref-type="sec"} according to the previously published paper \[[@B13]\]. The comparison between the results determined by the present method with HPLC-MS method was indicated in [Table 8](#tab8){ref-type="table"}.

[Table 8](#tab8){ref-type="table"} shows a good agreement between the proposed method and HPLC-MS where the relative differences of two methods were less than 11%. Furthermore, the standard deviation of the proposed method is almost lower than that of HPLC-MS. Our results indicate that the extractive spectrophotometric determination of FQs using BTB dye in chloroform is a very good method to quantify the FQ in pharmaceutical formulations.

4. Conclusions {#sec4}
==============

We have reported a new method when using BTB as an anionic dyes for the extractive spectrophotometric determination of ciprofloxacin (CFX), levofloxacin (LFX), and ofloxacin (OFX) in different pharmaceutical drugs (tablets and infusions). The methods have the advantages of simplicity without heating, pH-adjustment, and high sensitivity. The limit of detection (LOD) values are 0.084 *µ*g/mL for CFX, 0.101 *µ*g/mL for LFX, and 0.105 *µ*g/mL for OFX. No interference from common excipients was confirmed. The stoichiometry complexes of FQs and BTB determined by Job\'s method of continuous variation were found to be 1 : 1. The developed and validated methods are indicated as the acceptable precision and accuracy, and recovery of the drugs and suitable for routine analysis of drugs in pharmaceutical formulations. The results of some real samples by the present method that were compared with HPLC-MS method with the relative differences are less than 11%, indicating that the present method is good for determination of FQs in pharmaceutical formulations.
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###### 

The conditional stability constants (*K* ~f~) of the ion-pair complexes for FQs.

  Sample          *V* ~drug~ (mL)   *V* ~BTB~ (mL)   *A*     *n*      *n* ^⋀^ *n*   \[1 − (*A*/*A* ~*m*~)\]^*n*+2^   *K* ~f~         log *K* ~f~   Mean
  --------------- ----------------- ---------------- ------- -------- ------------- -------------------------------- --------------- ------------- ----------
  Ofloxacin                                                                                                                                        
  1               0.25              2.25             0.202   0.1111   0.7834        0.3116                           50204.7802      4.7007        **6.08**
  2               0.5               2                0.272   0.2500   0.7071        0.1486                           157048.9127     5.1960         
  3               0.75              1.75             0.336   0.4286   0.6955        0.0512                           572507.7789     5.7578         
  4               1                 1.5              0.419   0.6667   0.7631        0.0035                           9562329.8320    6.9806         
  5               1.25              1.25             0.476   1.0000   1.0000        0.0000                           \_              \_             
  6               1.5               1                0.432   1.5000   1.8371        0.0002                           59414177.6247   7.7739         
  7               1.75              0.75             0.356   2.3333   7.2213        0.0026                           1172246.1806    6.0690         
                                                                                                                                                   
  Levofloxacin                                                                                                                                     
  1               0.25              2.25             0.137   0.1111   0.7834        0.5749                           14789.8587      4.1700        **6.04**
  2               0.5               2                0.313   0.2500   0.7071        0.1856                           115961.3839     5.0643         
  3               0.75              1.75             0.432   0.4286   0.6955        0.0426                           708574.1920     5.8504         
  4               1                 1.5              0.559   0.6667   0.7631        0.0005                           67745245.6475   7.8309         
  5               1.25              1.25             0.594   1.0000   1.0000        0.0000                           \_              \_             
  6               1.5               1                0.53    1.5000   1.8371        0.0004                           34165312.8945   7.5336         
  7               1.75              0.75             0.426   2.3333   7.2213        0.0042                           682897.0665     5.8344         
                                                                                                                                                   
  Ciprofloxacin                                                                                                                                    
  1               0.25              2.25             0.392   0.1111   0.7834        0.2112                           83530.0520      4.9218        **5.91**
  2               0.5               2                0.452   0.2500   0.7071        0.1265                           178145.0100     5.2508         
  3               0.75              1.75             0.564   0.4286   0.6955        0.0345                           828480.0305     5.9183         
  4               1                 1.5              0.661   0.6667   0.7631        0.0036                           8522213.4055    6.9306         
  5               1.25              1.25             0.752   1.0000   1.0000        0.0000                           \_              \_             
  6               1.5               1                0.615   1.5000   1.8371        0.0026                           4572267.1248    6.6601         
  7               1.75              0.75             0.538   2.3333   7.2213        0.0043                           608798.6008     5.7845         

---, not determined.

###### 

Analytical characteristics of the proposed methods (*n*=6).

  Parameters                                                                                                                                             Proposed methods                  
  ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------ -------------- --------------
  Colour                                                                                                                                                 Yellow             Yellow         Yellow
  Wavelengths *λ* ~max~ (nm)                                                                                                                             418                415            420
  pH                                                                                                                                                     3.3                3.5            3.4
  Stability (h)                                                                                                                                          24                 24             24
  Shaking time (min)                                                                                                                                     2                  2              2
  Stoichiometric ratio                                                                                                                                   1 : 1              1 : 1          1 : 1
  Beer\'s law range (*µ*g/mL)                                                                                                                            1--35              0.5--25        0.5--25
  Limit of detection, LOD (*µ*g/mL)                                                                                                                      0.105              0.101          0.084
  Limit of quantitation, LOQ (*µ*g/mL)                                                                                                                   0.315              0.303          0.252
  Molar absorptivity (L/mol.cm)                                                                                                                          1.44 × 10^4^       2.07 × 10^4^   2.09 × 10^4^
  Sandell\'s sensitivity (*µ*g/cm^2^)                                                                                                                    0.068              0.048          0.046
                                                                                                                                                                                           
  Regression equation (*Y* = *bx* + *a*), where *Y* is the absorbance, *a* is the intercept, *b* is the slope, and *x* is the concentration in *μ*g/mL                                     
  Slope (*b*)                                                                                                                                            0.040              0.057          0.061
  Intercept (*a*)                                                                                                                                        0.0165             0.072          0.089
  Correlation coefficient (*R*)                                                                                                                          0.998              0.997          0.998

###### 

Evaluation of accuracy and precision of the proposed methods (*n*=6).

  Method          Additive concentration (*μ*g/mL)   Found concentration (*μ*g/mL)   Recovery (%)   RSD (%)   RE (%)
  --------------- ---------------------------------- ------------------------------- -------------- --------- --------
  Ofloxacin       5.00                               5.11                            102.19         2.31      2.2
  10.00           10.26                              102.64                          1.34           2.6       
  15.00           14.89                              99.25                           0.88           −0.73     
                                                                                                              
  Levofloxacin    5.00                               5.16                            102.70         2.03      2.8
  10.00           10.16                              101.56                          1.10           1.6       
  15.00           14.82                              98.80                           0.50           −1.2      
                                                                                                              
  Ciprofloxacin   5.00                               5.13                            102.71         1.92      2.6
  10.00           9.74                               97.41                           0.52           −2.6      
  15.00           14.60                              97.33                           0.57           −2.7      

###### 

The results of analysis of pharmaceutical preparation and standard of fluoroquinolones by two different analysts and instruments (*n*=6).

  Method                                                                                             Different instruments   Different analysts                         
  -------------------------------------------------------------------------------------------------- ----------------------- -------------------- ------ ------- ------ ------
  Ofloxacin-BTB pure ofloxacin (10 *µ*g·mL^−1^) Mekopharm (200 mg ofloxacin per tablet)              10.21                   0.19                 1.86   9.93    0.24   2.42
  199                                                                                                0.57                    0.29                 196    0.76    0.39   
                                                                                                                                                                        
  Levofloxacin-BTB pure levofloxacin (10 *µ*g·mL^−1^) Stada (500 mg levofloxacin per tablet)         10.16                   0.15                 1.48   10.19   0.21   2.06
  498                                                                                                0.61                    0.12                 501    0.85    0.17   
                                                                                                                                                                        
  Ciprofloxacin-BTB pure ciprofloxacin (10 *µ*g·mL^−1^) Hasancip (500 mg ciprofloxacin per tablet)   9.85                    0.18                 1.83   10.12   0.25   2.47
  502                                                                                                0.64                    0.13                 497    0.92    0.19   

###### 

The effect of excipients on the determination of fluoroquinolones (10 *µ*g/mL).

  Recovery (%) ± SD                                           
  -------------------- ----- --------------- ---------------- ---------------
  Magnesium stearate   500   102.04 ± 0.12   101.23 ± 0.089   98.53 ± 0.91
  Glucose              250   100.17 ± 0.16   99.04 ± 0.14     99.08 ± 0.062
  Lactose              500   99.92 ± 0.21    100.20 ± 0.12    99.73 ± 0.21
  Starch               200   100.96 ± 0.24   98.89 ± 0.13     101.31 ± 0.17
  Sodium chloride      500   100.13 ± 0.24   100.15 ± 0.11    99.75 ± 0.16

###### 

The comparison of present study with other spectrophotometric methods.

  Drug                              Reagent                    *λ* ~max~ (nm)   Range of determination (*μ*g/mL)   Molar absorptivity (L/mol·cm)                                                        Remarks          Reference
  --------------------------------- -------------------------- ---------------- ---------------------------------- ------------------------------------------------------------------------------------ ---------------- ------------
  Ciprofloxacin                     Co (II) tetrathiocyanate   623              20--240                            8.38 × 10^2^                                                                         Less sensitive   \[[@B34]\]
  Supracene violet 3                575                        2.5--30          8.62 × 10^3^                       Less sensitive                                                                       \[[@B35]\]       
  Eosin Y                           547                        2--8             3.56 × 10^4^                       Less stable colour                                                                   \[[@B36]\]       
  Merbromin                         545                        2--15            1.23 × 10^4^                       Addition of CN^--^to inhibit Hg^+2^ ions                                                              
  Ce(IV)- MBTH                      630                        10--50           ---                                Involves shaking time                                                                \[[@B17]\]       
  Tris(o-phenanthroline) iron(II)   510                        0.04--7.2        3.4 × 10^4^                        Involves shaking time and heating                                                    \[[@B18]\]       
  Tris (bipyridyl) iron(II)         522                        0.05--9          2.95 × 10^4^                       Involves shaking time and heating                                                                     
  CL                                520                        16--96           ---                                Involves shaking time and heating                                                    \[[@B16]\]       
  TCNE                              335                        0.25--15         ---                                Involves shaking time and heating                                                                     
  Sudan II                          550                        0.8--7.1         5.3 × 10^4^                        Narrow linear range                                                                  \[[@B8]\]        
  Congo red                         517                        0.5--6.0         2.83 × 10^4^                                                                                                                             
  Gentian violet                    585                        0.5--10          2.21 × 10^4^                                                                                                                             
  Brilliant blue G                  610                        0.5--6.0         2.86 × 10^4^                       Narrow linear range and required pH adjustment                                       \[[@B37]\]       
  Bromocresol green                 412                        1--20            2.28 × 10^4^                       Required pH adjustment                                                               \[[@B14]\]       
  BTB                               420                        0.5--25          2.09 × 10^4^                       Highly sensitive with wide linear dynamic ranges, no heating, and no pH adjustment   This study       
                                                                                                                                                                                                                         
  Levofloxacin                      Chloranilic acid           521              15--250                            1.2 × 10^3^                                                                          Less sensitive   \[[@B14]\]
  Bromocresol green                 411                        1--20            2.16 × 10^4^                       Required pH adjustment                                                                                
  Eosin Y                           547                        2--8             4.83 × 10^4^                       Less stable colour                                                                   \[[@B36]\]       
  Merbromin                         545                        2--15            1.58 × 10^4^                       Addition of CN^--^to inhibit Hg^+2^ ions                                                              
  Cobalt (II) tetrathiocyanate      623                        20--240          ---                                Less sensitive                                                                       \[[@B34]\]       
  Bromophenol blue                  424                        1.85--31.5       1.98 × 10^4^                       Required pH adjustment                                                               \[[@B19]\]       
  Bromocresol green                 428                        1.85--25         1.82 × 10^4^                                                                                                                             
  BTB                               415                        0.5--25          2.07 × 10^4^                       Highly sensitive with wide linear dynamic ranges, no heating, and no pH-adjustment   This study       
                                                                                                                                                                                                                         
  Ofloxacin                         Supracene violet 3         575              2.5--25                            1.09 × 10^4^                                                                         Less sensitive   \[[@B35]\]
  Tropaeolin 000                    485                        2.5--30          8.23 × 10^2^                       Less sensitive                                                                                        
  Sudan II                          560                        0.8--8.4         2.97 × 10^4^                       Narrow linear range                                                                  \[[@B8]\]        
  Congo red                         530                        0.5--5.5         3.29 × 10^4^                                                                                                                             
  Gentian violet                    575                        0.8--11          2.51 × 10^4^                                                                                                                             
  Bromocresol purple                400                        1.0--16.0        2\. 4 × 10^4^                      Required pH adjustment                                                               \[[@B38]\]       
  Bromocresol green                 410                        1.0--16.0        1.96 × 10^4^                       Required pH adjustment                                                                                
  Bromophenol blue                  410                        5--25            1.03 × 10^4^                       Required close pH control and involved extraction steps                              \[[@B20]\]       
  Bromothymol blue                  415                        2--15            2.01 × 10^4^                                                                                                                             
  Bromocresol purple                410                        2--20            1.64 × 10^4^                                                                                                                             
  Bromothymol blue                  415                        1--35            1.44 × 10^4^                       Highly sensitive with wide linear dynamic ranges, no heating, and no pH-adjustment   This study       

###### 

Determination of the studied drugs in their pharmaceutical preparations using the proposed method (*n*=6).

  Pharmaceutical preparation   Hasancip tablet   Kacipro tablet   Shandong infusion   Hebei infusion   Levofloxacin Stada   Levofloxacin DHG   Ofloxacin mekopharm
  ---------------------------- ----------------- ---------------- ------------------- ---------------- -------------------- ------------------ ---------------------
  Labeled amount (mg/form)     500/tablet        500/tablet       200/100 mL          200/100 mL       500/tablet           500/tablet         200/tablet
  Recovery (%) ± SD            98.89 ± 0.23      101.20 ± 0.20    97.41 ± 0.42        97.69 ± 0.36     99.53 ± 0.17         101.01 ± 0.35      99.58 ± 0.46

###### 

Amount of some fluoroquinolone antibiotics determined by the proposed method and HPLC-MS.

  Sample                         Amount (mg/tablet)   Difference (%)   
  ------------------------------ -------------------- ---------------- -------
  Ciprofloxacin-Hasancip table   494.45 ± 11.63       446.93 ± 15.84   10.63
  Ofloxacin mekopharm            199.16 ± 0.85        202.00 ± 2.72    −1.41
  Levofloxacin DHG               505.05 ± 17.33       480.55 ± 54.16   5.10
  Levofloxacin Stada             497.65 ± 9.24        486.04 ± 9.24    2.39

[^1]: Academic Editor: Bengi Uslu
